Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 5
Submit an article Journal homepage
569
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population

Siddhesh A. Kamat HealthCore, Inc., Wilmington, DE, USACorrespondence[email protected]
,
Michael F. Bullano AstraZeneca LP, Wilmington, DE, USA
,
Chun-Lan Chang HealthCore, Inc., Wilmington, DE, USA
,
Sanjay K. Gandhi AstraZeneca LP, Wilmington, DE, USA
&
Mark J. Cziraky HealthCore, Inc., Wilmington, DE, USA
Pages 961-968 | Accepted 09 Feb 2011, Published online: 07 Mar 2011

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Louise E. Bartlett, Nicole Pratt & Elizabeth E. Roughead. (2018) Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?. Current Medical Research and Opinion 34:2, pages 305-311.
Read now

Articles from other publishers (21)

Qiaoli Su, Ying Liu, Guogang Zhang, Li Xu, Min Wang, Shifang Mei, Genevieve Garon, Yanzhen Wu, Qiang Lv & Changsheng Ma. (2023) Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial. Advances in Therapy 40:12, pages 5285-5299.
Crossref
Qiran Wei, Jiting Zhou, Hongchao Li, Luying Wang, Yao Wu, Aixia Ma & Xin Guan. (2023) Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
François Schiele, Leopoldo Pérez de Isla, Marcello Arca & Charalambos Vlachopoulos. (2021) Is it Time for Single-Pill Combinations in Dyslipidemia?. American Journal of Cardiovascular Drugs 22:3, pages 239-249.
Crossref
Erin D. Michos & Keith C. Ferdinand. (2022) Lipid-lowering for the prevention of cardiovascular disease in the new era: A practical approach to combination therapy: Lipid-lowering and combination therapy. European Atherosclerosis Journal 1:1, pages 30-36.
Crossref
Giorgio Bosso, Mariarosaria De Luca, Giovanni Alma, Vincenzo Carbone, Ferdinando Ferrara, Biagio Fimiani, Franco Guarnaccia, Alessandro Iandolo, Sabato Murolo, Maurizio Olivares, Emanuele Romeo, Giosuè Santoro, Antonio Valvano, Giovanni Zito & Ugo Oliviero. (2021) ALERT-LDL: adherence to guidelines in the treatment of patients with dyslipidemia. Internal and Emergency Medicine 17:2, pages 387-395.
Crossref
Federico Rea, Laura Savaré, Giovanni Corrao & Giuseppe Mancia. (2021) Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe. Advances in Therapy 38:10, pages 5270-5285.
Crossref
Katrin Gebauer, Kerstin Wintersohl, Rike Kraska, Katja Kortendick, Ulrike Fahrland, Eva Freisinger, Matthias Meyborg, Jacqueline Stella, Christiane Engelbertz, Holger Reinecke & Nasser Malyar. (2020) Medikamentöse Sekundärprävention bei Patienten mit peripherer arterieller VerschlusskrankheitMedication-based secondary prevention in patients with peripheral arterial occlusive disease. Herz 46:S2, pages 280-286.
Crossref
Eman Alefishat, Anan S. Jarab, Walid Al-Qerem & Lina Abu-Zaytoun. (2021) Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia. Healthcare 9:7, pages 813.
Crossref
Ana Baumgartner, Katarina Drame, Stijn Geutjens & Marja Airaksinen. (2020) Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review. Pharmaceutics 12:2, pages 190.
Crossref
Sofa D. Alfian, Ivan S. Pradipta, Eelko Hak & Petra Denig. (2019) A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medications. Journal of Clinical Epidemiology 108, pages 44-53.
Crossref
Priti P. Pednekar, Tamás Ágh, Maria Malmenäs, Amit D. Raval, Bryan M. Bennett, Bijan J. Borah, David S. Hutchins, Elizabeth Manias, Allison F. Williams, Mickaël Hiligsmann, Adina Turcu-Stiolica, John E. Zeber, Lusine Abrahamyan, Thomas J. Bunz & Andrew M. Peterson. (2019) Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health 22:2, pages 139-156.
Crossref
Alan S. Go, Dongjie Fan, Sue Hee Sung, Alda I. Inveiss, Victoria Romo-LeTourneau, Usha G. Mallya, Susan Boklage & Joan C. Lo. (2017) Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. American Heart Journal 194, pages 25-38.
Crossref
Andrea L. Schaffer, Nicholas A. Buckley & Sallie-Anne Pearson. (2017) Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy. Pharmacoepidemiology and Drug Safety 26:12, pages 1465-1473.
Crossref
Michel Farnier, Helen M. Colhoun, William J. Sasiela, Jay M. Edelberg, Gaëlle Asset & Jennifer G. Robinson. (2017) Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years. Journal of Clinical Lipidology 11:4, pages 986-997.
Crossref
Louise E. Bartlett, Nicole Pratt & Elizabeth E. Roughead. (2017) Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?. British Journal of Clinical Pharmacology 83:1, pages 202-210.
Crossref
. (2016) Parte III. Control clínico del tratamiento con fenofibrato. Clínica e Investigación en Arteriosclerosis 28, pages 20-25.
Crossref
Gábor Simonyi & Tamás Ferenci. (2015) Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy. Orvosi Hetilap 156:4, pages 141-145.
Crossref
Danielle P. Porter & Bill Guyer. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs 482 508 .
Patricia Maningat, Bruce R. Gordon & Jan L. Breslow. (2012) How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?. Current Atherosclerosis Reports 15:1.
Crossref
Joanne Lafleur, Carrie McAdam-Marx, George L White, Joseph L Lyon & Gary M Oderda. (2012) Comparing Medication Adherence Methods in Lipid-Modifying Therapy. Journal of Pharmacy Technology 28:2, pages 58-67.
Crossref
Katherine A. Lyseng-Williamson. (2012) Ezetimibe/Simvastatin: A Guide to its Clinical Use in Hypercholesterolemia. American Journal Cardiovascular Drugs 12:1, pages 49-56.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.